Millennium Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-31,090
Closed -$1.92M 4375
2014
Q2
$1.92M Buy
31,090
+260
+0.8% +$15.1K 0.01% 1809
2014
Q1
$2M Buy
30,830
+14,540
+89% +$983K 0.01% 1778
2013
Q4
$917K Buy
+16,290
New +$915K ﹤0.01% 2345

Other funds holding OREX

Millennium Management's OREX Position: Q2 2018 in Review

Millennium Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 14,130 shares — an estimated $3K sold.

Millennium Management first reported a position in OREX in Q2 2013 and held it in 15 quarters. The position peaked at $23M in Q2 2015. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Millennium Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Millennium Management sold 14,130 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $3K.
  • Millennium Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 15 quarters.
  • Millennium Management's Orexigen Therapeutics, Inc. position peaked at $23M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.